title: Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosis.
abstract: The purpose of the study was to report a case of choroidal neovascularization (CNV) secondary to ocular toxoplasmosis in an 18-year-old female patient. She was treated with a single intravitreal injection of ranibizumab. The CNV resolved as confirmed by fluorescein angiography and optical coherence tomography (OCT). The visual acuity improved to 20/30, which was maintained till the last follow-up visit at two years, without requisition of a repeat injection.
authors.affiliation: Department of Cornea and Anterior Segment, The Eye Super Specialities, Mumbai, India. urminikunj@hotmail.com
authors.forename: Nikunj J
authors.initials: NJ
authors.lastname: Shah
authors.forename: Urmi N
authors.initials: UN
authors.lastname: Shah
mesh_terms: D000293:Adolescent; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D015862:Choroid Diseases / Q000150:complications / Q000473:pathology; D020256:Choroidal Neovascularization / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology*; D002921:Cicatrix / Q000150:complications / Q000473:pathology; D005260:Female; D005451:Fluorescein Angiography; D005654:Fundus Oculi; D006801:Humans; D058449:Intravitreal Injections; D000069579:Ranibizumab; D012164:Retinal Diseases / Q000150:complications / Q000473:pathology; D041623:Tomography, Optical Coherence; D014126:Toxoplasmosis, Ocular / Q000150:complications*
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069579:Ranibizumab